Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?

• Status: Unknown status
• Trial end date: 2021-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The Neutrophil to Lymphocyte Ratio (NLR) is a frequently used biomarker of the systemic inflammatory response and is considered one of the most sensitive markers of inflammation. Many studies have documented the association between the use of opioid drugs in the acute phase -as it can be considered the use during general anesthesia- and the increase of the NLR value. Such increase could determine a temporary phase of immunodepression in the immediate post operative period with consequent increase of the inflammatory state.

This study intends to assess whether different anesthetic techniques can be associated with different variations of the intra-patient NLR value between pre- and post-surgery. Patient will be randomized to receive either local regional anesthesia protocols with thoracic wall blocks (PEC I and serratus plane block) associated with opioid-free general anesthesia (PECS + Opioid-free GA) or general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centro di Riferimento Oncologico - Aviano
• Treatments: Analgesics, Opioid; Anesthetics; Midazolam

Criteria

Inclusion Criteria:

• First diagnosis of histologically confirmed breast cancer

• Candidate to external quadrantectomy and axillary surgery (biopsy of the sentinel lymph node and possible axillary lymphadenectomy)

• Able to provide adequate informed consent

• With intact cognitive abilities

Exclusion Criteria:

• Ongoing pregnancy

• In therapy or in follow-up for other cancers at the time of the study

• Concurrent therapy with opioids or other drugs, for chronic pain conditions related to cancer or other diseases

• History of documented allergy or previous adverse reaction to local anesthetics

• Documented history of anesthesiology related problems during previous surgical interventions or history of problems in airway management

• Unable to comply to study protocol schedule for logistic or other reasons

• Refusal to participate to the study (absence of signed informed consent)